IRVINE, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- On November 8, 2017, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) and Genesis Healthcare, Inc. (“Genesis”) entered into a memorandum of understanding (the “Genesis Exodus MOU”) relating to the remaining 43 facilities leased to Genesis (the “Genesis Exodus Facilities”) as detailed in the Current Report on Form 8-K filed by Sabra with the SEC on November 13, 2017. The Company does not expect the transactions contemplated by the Genesis Exodus MOU to impact the Company’s previously issued full year guidance for 2017 or 2018.
ABOUT SABRA
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified, without limitation, by the use of “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. Forward-looking statements in this release include all statements regarding our outlook for the full years 2017 and 2018.
Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the “SEC”), including Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2016 and Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2017. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.
CONTACT
Investor & Media Inquiries: (888) 393-8248 or investorinquiries@sabrahealth.com
Source: Sabra Health Care REIT, Inc.